After a freak accident left him blind and in agony, Phil Durst thought hope was lost. Then, a world-first stem cell trial changed everything.

Every year, thousands of people are blinded suddenly, like Durst, by injuries to their cornea, the dome-shaped lenses that cap each iris. These injuries are often debilitating. In the weeks after his ...

Serious diseases affecting the transparent part of the eye, called the cornea, are very difficult to treat because this ...

Researchers at Spain’s University of Granada have developed an artificial cornea made from the scales of several fish ​species commonly found in markets, which could become a ‌lower-cost alternative ...

Background Ocular chronic graft versus host disease (oGVHD) seriously affects ocular surface, which often results in corneal ...

University of Pittsburgh School of Medicine researchers have developed an early-stage, experimental "living eye drop" that ...

Spanish scientists at the University of Granada have innovated a low-cost artificial cornea using fish scales. This ...

OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and for inflammatory eye ...

A Bengaluru-based biotech startup is developing a breakthrough solution for corneal damage. Pandorum Technologies’ “Liquid Cornea” could reshape how doctors treat vision loss in the future.

University of Pittsburgh School of Medicine researchers have developed an early-stage, experimental "living eye drop" that uses naturally occurring eye bacteria to support corneal wound healing. The ...